Vaccines for children are on the way

The FDA is expected to approve the Pfizer vaccine for kids 12 to 15 by next week.

There’s good news for vaccination efforts in the U.S. Pfizer has applied for – and the Food and Drug Administration is expected to approve – emergency use authorization for its COVID-19 vaccine in 12- to 15-year-olds.

What Happened: Pfizer has spent months studying the use of its COVID-19 vaccines in younger Americans. Initial results, released in March, showed the two-dose vaccine was 100% effective in people age 12 to 15.

WMUK logo

NowKalamazoo is supported by WMUK Public Media. Offering news and conversation from NPR at 102.1FM and classical music & local arts at 89.9FM. Celebrating 70 years of public radio excellence!

Listen on the radio dial or smart speaker, stream online at, or on the WMUK app for mobile devices.

The Pfizer vaccine is already approved for use in people age 16 and older.

A federal official interviewed by the Associated Press said it was expected the FDA would approve the use of the vaccine in the younger age group by next week, if not sooner.

Pfizer is also testing its vaccine in even younger people and the official anticipates they could get approval for that usage by this fall.

You can read the full story on APNews.